VA106483 Phase IIb trial for nocturia
2 February 2010
Vantia Therapeutics' lead candidate VA106483 enters Phase IIb trial for nocturia more »
VA111913 Phase II trial in dysmenorrhoea
6 October 2009
Vantia Therapeutics' lead candidate VA111913 enters Phase II POC trial in dysmenorrhoea more »
Vantia Therapeutics currently has no vacancies.
